[Form 4] GoodRx Holdings, Inc. Insider Trading Activity
GoodRx Holdings, Inc. (GDRX): This Form 4 discloses that on September 4, 2025 Spectrum Equity-related entities converted Class B shares into Class A on a one-for-one basis and distributed 5,983,984 Class A shares pro rata from Spectrum Equity VII, L.P. to its partners for no consideration. Related Spectrum entities also show beneficial ownership changes across multiple funds: Spectrum Equity VII, L.P. reflects 5,983,984 Class A shares acquired and later disposed of on a pro rata basis, while Spectrum VII Investment Managers' Fund and Spectrum VII Co-Investment Fund show smaller acquired amounts (10,243 and 5,773) and subsequent sales at $4.05 per share on September 5, 2025, leaving 0 reported shares for those funds.
GoodRx Holdings, Inc. (GDRX): In questo Modulo 4 si segnala che il 4 settembre 2025 entità legate a Spectrum Equity hanno convertito le azioni di Classe B in azioni di Classe A con rapporto uno a uno e hanno distribuito 5.983.984 azioni di Classe A pro rata da Spectrum Equity VII, L.P. ai suoi soci a titolo gratuito. Altre entità correlate di Spectrum mostrano variazioni nella proprietà effettiva su più fondi: Spectrum Equity VII, L.P. registra l’acquisto di 5.983.984 azioni di Classe A poi distribuite pro rata, mentre Spectrum VII Investment Managers' Fund e Spectrum VII Co-Investment Fund indicano importi minori acquisiti (10.243 e 5.773) e successive vendite a $4,05 per azione il 5 settembre 2025, lasciando 0 azioni dichiarate per questi fondi.
GoodRx Holdings, Inc. (GDRX): Este Formulario 4 revela que el 4 de septiembre de 2025 entidades relacionadas con Spectrum Equity convirtieron acciones de Clase B en Clase A a razón de una por una y repartieron 5.983.984 acciones Clase A prorrata desde Spectrum Equity VII, L.P. entre sus socios sin contraprestación. Otras entidades vinculadas de Spectrum también muestran cambios en la propiedad beneficiaria en varios fondos: Spectrum Equity VII, L.P. refleja la adquisición de 5.983.984 acciones Clase A que luego se distribuyeron prorrata, mientras que Spectrum VII Investment Managers' Fund y Spectrum VII Co-Investment Fund registran importes menores adquiridos (10.243 y 5.773) y ventas posteriores a $4,05 por acción el 5 de septiembre de 2025, quedando con 0 acciones reportadas para esos fondos.
GoodRx Holdings, Inc. (GDRX): 이 Form 4 보고서에 따르면 2025년 9월 4일 Spectrum Equity 관련 기관들이 클래스 B 주식을 1대1 비율로 클래스 A 주식으로 전환하고 Spectrum Equity VII, L.P.로부터 파트너들에게 5,983,984주의 클래스 A 주식을 무상으로 비례 배분했습니다. 관련 Spectrum 계열사들은 여러 펀드에 걸쳐 실소유권 변동도 보고하고 있습니다. Spectrum Equity VII, L.P.는 5,983,984주의 클래스 A를 취득한 뒤 비례 배분으로 처분한 것으로 나타나며, Spectrum VII Investment Managers' Fund 및 Spectrum VII Co-Investment Fund는 소량(10,243 및 5,773)을 취득한 후 2025년 9월 5일 주당 $4.05에 매각하여 해당 펀드들의 신고 주식 수는 0가 되었습니다.
GoodRx Holdings, Inc. (GDRX) : Ce formulaire 4 indique que le 4 septembre 2025 des entités liées à Spectrum Equity ont converti des actions de classe B en classe A au taux d’un pour un et ont distribué 5 983 984 actions de classe A pro rata depuis Spectrum Equity VII, L.P. à leurs associés sans contrepartie. D’autres entités associées de Spectrum montrent des changements de détention bénéficiaire sur plusieurs fonds : Spectrum Equity VII, L.P. enregistre l’acquisition de 5 983 984 actions de classe A ensuite réparties pro rata, tandis que Spectrum VII Investment Managers' Fund et Spectrum VII Co-Investment Fund ont acquis des montants plus modestes (10 243 et 5 773) puis vendu ces actions le 5 septembre 2025 à 4,05 $ par action, laissant 0 action déclarée pour ces fonds.
GoodRx Holdings, Inc. (GDRX): Dieses Formular 4 gibt an, dass am 4. September 2025 von Spectrum Equity verbundene Einheiten Stammaktien der Klasse B eins zu eins in Klasse A umgewandelt und 5.983.984 Klasse-A-Aktien pro rata von Spectrum Equity VII, L.P. an seine Partner ohne Gegenleistung verteilt wurden. Weitere Spectrum-nahe Einheiten zeigen Veränderungen der wirtschaftlichen Eigentümerschaft in mehreren Fonds: Spectrum Equity VII, L.P. verzeichnet den Erwerb von 5.983.984 Klasse-A-Aktien, die später pro rata veräußert wurden, während der Spectrum VII Investment Managers' Fund und der Spectrum VII Co-Investment Fund kleinere Mengen (10.243 bzw. 5.773) erworben und am 5. September 2025 zu $4,05 pro Aktie verkauft haben, womit für diese Fonds 0 gemeldete Aktien verbleiben.
- Conversion completed: Class B shares converted to Class A on a one-for-one basis, simplifying equity class structure for the reporting entities.
- Transparent disclosure: Filing provides clear transaction dates, quantities, and sale price ($4.05) for the dispositions, aiding investor visibility into insider activity.
- Large distribution and disposition: A pro rata distribution of 5,983,984 Class A shares was made and affiliated funds sold shares the following day, which may be viewed as insider monetization.
- Reported holdings reduced to zero: Spectrum VII Investment Managers' Fund and Spectrum VII Co-Investment Fund reported sales that left 0 shares following the transactions.
Insights
TL;DR: Conversion and large pro rata distribution occurred; some affiliated funds sold converted shares the next day at $4.05, reducing reported holdings to zero.
The filing documents an internal one-for-one conversion of Class B into Class A shares and a pro rata distribution of 5,983,984 Class A shares by Spectrum Equity VII, L.P. to its partners for no consideration on September 4, 2025. Subsequent Form 4 lines show sales by affiliated funds on September 5, 2025 at $4.05 per share that reduced reported holdings to zero for those funds. For investors, this clarifies changes in insider ownership and immediate monetization by specific affiliated entities; the filing contains no financial performance data or commentary on company operations.
TL;DR: Transaction reflects ownership structure actions among Spectrum Equity entities rather than a direct operational development at GoodRx.
The report details conversion mechanics and internal distributions among Spectrum Equity VII and related entities, and identifies the individuals who may share voting/dispositive power. It notes that the general partner and management entities effected the transactions and that named managers disclaim beneficial ownership except to the extent of pecuniary interest. This is a disclosure-important governance event but appears procedural rather than signaling a change in corporate control or policy.
GoodRx Holdings, Inc. (GDRX): In questo Modulo 4 si segnala che il 4 settembre 2025 entità legate a Spectrum Equity hanno convertito le azioni di Classe B in azioni di Classe A con rapporto uno a uno e hanno distribuito 5.983.984 azioni di Classe A pro rata da Spectrum Equity VII, L.P. ai suoi soci a titolo gratuito. Altre entità correlate di Spectrum mostrano variazioni nella proprietà effettiva su più fondi: Spectrum Equity VII, L.P. registra l’acquisto di 5.983.984 azioni di Classe A poi distribuite pro rata, mentre Spectrum VII Investment Managers' Fund e Spectrum VII Co-Investment Fund indicano importi minori acquisiti (10.243 e 5.773) e successive vendite a $4,05 per azione il 5 settembre 2025, lasciando 0 azioni dichiarate per questi fondi.
GoodRx Holdings, Inc. (GDRX): Este Formulario 4 revela que el 4 de septiembre de 2025 entidades relacionadas con Spectrum Equity convirtieron acciones de Clase B en Clase A a razón de una por una y repartieron 5.983.984 acciones Clase A prorrata desde Spectrum Equity VII, L.P. entre sus socios sin contraprestación. Otras entidades vinculadas de Spectrum también muestran cambios en la propiedad beneficiaria en varios fondos: Spectrum Equity VII, L.P. refleja la adquisición de 5.983.984 acciones Clase A que luego se distribuyeron prorrata, mientras que Spectrum VII Investment Managers' Fund y Spectrum VII Co-Investment Fund registran importes menores adquiridos (10.243 y 5.773) y ventas posteriores a $4,05 por acción el 5 de septiembre de 2025, quedando con 0 acciones reportadas para esos fondos.
GoodRx Holdings, Inc. (GDRX): 이 Form 4 보고서에 따르면 2025년 9월 4일 Spectrum Equity 관련 기관들이 클래스 B 주식을 1대1 비율로 클래스 A 주식으로 전환하고 Spectrum Equity VII, L.P.로부터 파트너들에게 5,983,984주의 클래스 A 주식을 무상으로 비례 배분했습니다. 관련 Spectrum 계열사들은 여러 펀드에 걸쳐 실소유권 변동도 보고하고 있습니다. Spectrum Equity VII, L.P.는 5,983,984주의 클래스 A를 취득한 뒤 비례 배분으로 처분한 것으로 나타나며, Spectrum VII Investment Managers' Fund 및 Spectrum VII Co-Investment Fund는 소량(10,243 및 5,773)을 취득한 후 2025년 9월 5일 주당 $4.05에 매각하여 해당 펀드들의 신고 주식 수는 0가 되었습니다.
GoodRx Holdings, Inc. (GDRX) : Ce formulaire 4 indique que le 4 septembre 2025 des entités liées à Spectrum Equity ont converti des actions de classe B en classe A au taux d’un pour un et ont distribué 5 983 984 actions de classe A pro rata depuis Spectrum Equity VII, L.P. à leurs associés sans contrepartie. D’autres entités associées de Spectrum montrent des changements de détention bénéficiaire sur plusieurs fonds : Spectrum Equity VII, L.P. enregistre l’acquisition de 5 983 984 actions de classe A ensuite réparties pro rata, tandis que Spectrum VII Investment Managers' Fund et Spectrum VII Co-Investment Fund ont acquis des montants plus modestes (10 243 et 5 773) puis vendu ces actions le 5 septembre 2025 à 4,05 $ par action, laissant 0 action déclarée pour ces fonds.
GoodRx Holdings, Inc. (GDRX): Dieses Formular 4 gibt an, dass am 4. September 2025 von Spectrum Equity verbundene Einheiten Stammaktien der Klasse B eins zu eins in Klasse A umgewandelt und 5.983.984 Klasse-A-Aktien pro rata von Spectrum Equity VII, L.P. an seine Partner ohne Gegenleistung verteilt wurden. Weitere Spectrum-nahe Einheiten zeigen Veränderungen der wirtschaftlichen Eigentümerschaft in mehreren Fonds: Spectrum Equity VII, L.P. verzeichnet den Erwerb von 5.983.984 Klasse-A-Aktien, die später pro rata veräußert wurden, während der Spectrum VII Investment Managers' Fund und der Spectrum VII Co-Investment Fund kleinere Mengen (10.243 bzw. 5.773) erworben und am 5. September 2025 zu $4,05 pro Aktie verkauft haben, womit für diese Fonds 0 gemeldete Aktien verbleiben.